David Gionco, CAO at Stemline Therapeutics, holds 0.00 shares in Stemline Therapeutics (Ticker: STML), holds 53.49K shares in Savient Pharmaceuticals (Ticker: SVNTQ).

See the Hottest Stocks Based on Insider Trading >

David Gionco
Stemline Therapeutics (STML)
CAO

Ranked #73,877 out of 98,564 Corporate Insiders

Profitable Transactions

8 out of 13 Profitable Transactions

Average Return

-9.20%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

David Gionco does not currently own shares as a corporate insider.

A breakdown of David Gionco's holdings

See the Top Stocks by Insiders

Insider Roles

David Gionco does not currently hold a role as a corporate insider.

Roles that David Gionco holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Stemline Therapeutics
(STML)

Rating:Informative Sell

Date:Mar 15, 2019 - Mar 15, 2020

Return:+66.70%

The most profitable trade made by David Gionco

See the Latest Stocks Traded by Insiders

David Gionco's Trading History

STML

Stemline Therapeutics

Jun 10, 2020

―

Uninformative Buy

―

$0.00

SVNTQ

Savient Pharmaceuticals

Jul 25, 2012

―

Uninformative Buy

―

List of latest transactions for each holding click on a transaction to see David Gionco's performance on stock

See All Insider Trading from Today

David Gionco insider profile FAQ

What is the percentage of profitable transactions made by David Gionco?

The percentage of profitable transactions made by David Gionco is 62%.

What is the average return per transaction made by David Gionco?

The average return per transaction made by David Gionco is -9.20%.

What stocks does David Gionco hold?

David Gionco holds: STML, SVNTQ stocks.

What was David Gionco’s latest transaction?

David Gionco latest transaction was an Uninformative Buy of ―.

What was David Gionco's most profitable transaction?

David Gionco’s most profitable transaction was an Informative Sell of STML stock on March 15, 2019. The return on the trade was 66.70%.

What is David Gionco's role in Stemline Therapeutics?

David Gionco's role in Stemline Therapeutics is CAO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

David Gionco Insider Profile

David Gionco Stemline Therapeutics (STML)CAO